CYP3A4 is significant in cancer for several reasons. First, it metabolizes many chemotherapeutic agents, impacting their efficacy and toxicity. Second, its expression levels can vary significantly between individuals, influencing drug response and adverse effects. Lastly, some studies suggest that CYP3A4 may be involved in the activation or deactivation of potential carcinogens, affecting cancer risk.
